iSTAR Medical logo.png
iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials
June 08, 2022 07:00 ET | iSTAR Medical
For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...
iSTAR Medical logo.png
iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials
June 08, 2022 02:00 ET | iSTAR Medical
For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...
iSTAR Medical logo.png
iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland
May 10, 2022 02:00 ET | iSTAR Medical
For immediate release iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland The only commercially available MIGS device currently targeting the supraciliary...
iSTAR Medical logo.png
iSTAR Medical Continues Market Expansion with First MINIject® Surgeries in the UK
March 28, 2022 02:00 ET | iSTAR Medical
For immediate release iSTAR Medical Continues Market Expansion with First MINIject® Surgeries in the UK UK patients and surgeons now able to benefit from the only commercially available MIGS device...
iSTAR Medical logo.png
iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject
January 12, 2022 07:00 ET | iSTAR Medical
For immediate release iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject Pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the USPositive feedback from...
iSTAR Medical logo.png
iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject
January 12, 2022 02:00 ET | iSTAR Medical
For immediate release iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject Pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the USPositive feedback from...
iSTAR Medical logo.png
iSTAR Medical receives European market approval for glaucoma implant MINIject
November 17, 2021 07:00 ET | iSTAR Medical
iSTAR Medical receives European market approval for glaucoma implant MINIject The only commercially available, minimally invasive supraciliary device for glaucoma now approved First commercial...
iSTAR Medical receives European market approval for glaucoma implant MINIject
November 17, 2021 02:00 ET | iSTAR Medical
iSTAR Medical receives European market approval for glaucoma implant MINIject The only commercially available, minimally invasive supraciliary device for glaucoma now approved First commercial...
iSTAR Medical erhält europäische Marktzulassung für Glaukom-Implantat MINIject
November 17, 2021 02:00 ET | iSTAR Medical
Zur sofortigen Freigabe iSTAR Medical erhält europäische Marktzulassung für Glaukom-Implantat MINIject Das einzige kommerziell verfügbare, minimalinvasive supraziliäre Implantat für Glaukom jetzt...
iSTAR Medical krijgt goedkeuring voor de Europese markt voor het glaucoomimplantaat MINIject
November 17, 2021 02:00 ET | iSTAR Medical
Voor onmiddellijke publicatie iSTAR Medical krijgt goedkeuring voor de Europese markt voor het glaucoomimplantaat MINIject Het enige commercieel verkrijgbare, minimaal invasieve supraciliaire...